Skip to main content

previous disabled Page of 5
and
  1. Article

    Open Access

    Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study

    Potentially modifiable risk factors for hepatocellular carcinoma (HCC) have been investigated in observational epidemiology studies in East Asian and European populations, whereas the causal associations of mo...

    **aoxia Wei, Chenglei Yang, Qiuling Lin, Moqin Qiu, Qiu** Wen, Zihan Zhou in BMC Cancer (2024)

  2. Article

    Open Access

    Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

    High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, **** Wang, Ying Liang, **ao**g Yan in BMC Cancer (2024)

  3. Article

    Open Access

    METTL3-induced circ_0008345 contributes to the progression of colorectal cancer via the microRNA-182-5p/CYP1A2 pathway

    Circular RNA (circRNAs) have been found to play major roles in the progression of colorectal cancer (CRC). However, the functions of circ_0008345 (transcribed by PTK2) in regulating CRC development remain unde...

    Chaofeng Hou, **bo Liu, Junwei Liu, Danjie Yao, Fang Liang, Congpeng Qin in BMC Cancer (2024)

  4. Article

    Open Access

    Prognostic value of the Naples prognostic score in patients with intrahepatic cholangiocarcinoma after hepatectomy

    The Naples Prognostic Score (NPS), integrating inflammatory and nutritional biomarkers, has been reported to be associated with the prognosis of various malignancies, but there is no report on intrahepatic cho...

    Cheng-Fei Du, Zhen-Yu Gao, Zhu-Ding Xu, Zheng-Kang Fang, Zi-Chen Yu in BMC Cancer (2024)

  5. Article

    Open Access

    Effect of novel anti-tumor and anti-angiogenesis drug taurolactone on angiogenic factor AGGF1 and angiogenesis mimicry in patients with hepatocellular carcinoma

    Our study was to investigate the impact of taurolactone, a novel anti-tumor and anti-angiogenic drug, on AGGF1, an angiogenic factor, and angiogenesis mimicry in patients diagnosed with hepatocellular carcinom...

    Shao** Liu, Yinzhi Wei, Lei Nie, Ze Tang, Qi Lu, Qun Liang in BMC Cancer (2024)

  6. Article

    Open Access

    A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study

    Accurate microsatellite instability (MSI) testing is essential for identifying gastric cancer (GC) patients eligible for immunotherapy. We aimed to develop and validate a CT-based radiomics signature to predic...

    Peng-chao Zhan, Shuo Yang, **ng Liu, Yu-yuan Zhang, Rui Wang, Jia-xing Wang in BMC Cancer (2024)

  7. Article

    Open Access

    Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer

    The sialic acid binding Ig like lectin 15 (Siglec-15) was previously identified as tumor immune suppressor gene in some human cancers with elusive molecular mechanism to be elucidated. The continuous focus on ...

    **ngzhi Li, Ziji Liang, Jiexin Pan, Meng Zhang, **li Liu, Rong Hu in BMC Cancer (2024)

  8. Article

    Open Access

    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?

    The aim of this study was to compare the therapeutic value and treatment-related complications of radical hysterectomy with those of concurrent chemoradiotherapy (CCRT) for locally resectable (T1a2–T2a1) stage...

    Mei-ling Zhong, Yin-chuan Liu, Jian-tong Yang, Ya-nan Wang, Mei-hong Ao in BMC Cancer (2024)

  9. Article

    Open Access

    Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin

    Studies have shown that the absolute lymphocyte count (ALC) and the neutrophil-to-lymphocyte ratio (NLR) are related to the outcomes in patients with breast cancer receiving specific chemotherapies. However, t...

    Meng-**a Su, Hsiang-Wen Lin, Hanh T. H. Nguyen, Tien-Chao Lin, Chih-Jung Chen in BMC Cancer (2024)

  10. Article

    Open Access

    The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma

    Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are genera...

    Lu **e, **n Sun, Jie Xu, **n Liang, Kuisheng Liu, Kunkun Sun, Rongli Yang in BMC Cancer (2024)

  11. Article

    Open Access

    Development of a risk assessment model for cardiac injury in patients newly diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis in China

    Studies have revealed that acute myeloid leukemia (AML) patients are prone to combined cardiac injury. We aimed to identify hematological risk factors associated with cardiac injury in newly diagnosed AML pati...

    Linlu Ma, Qian Wang, **nqi Li, Yufeng Shang, Nan Zhang, **xian Wu in BMC Cancer (2024)

  12. Article

    Open Access

    Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review

    Lymphoplasmacyte-rich meningioma(LPM) is a rare subtype of meningioma with a low degree of malignancy and an overall preferable prognosis. The purpose of this article is to increase the understanding of the di...

    **aoxi Zhu, Yanhua Liu, Weiwei Guo, Qi Liang, Chengliang Pan, Bin Tan in BMC Cancer (2024)

  13. Article

    Open Access

    Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy

    Neoadjuvant chemotherapy (NAC) has become a standard treatment strategy for breast cancer (BC). However, owing to the high heterogeneity of these tumors, it is unclear which patient population most likely bene...

    Gengshen Yin, Liyuan Liu, Ting Yu, Lixiang Yu, Man Feng, Chengjun Zhou in Genome Medicine (2024)

  14. Article

    Open Access

    Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy

    Platelet distribution width (PDW), but not platelet count, was found to more comprehensively reflect platelet activity. The present study, thus, aimed to evaluate the prognostic value of PDW to lymphocyte rati...

    Zhi-Han Zhong, Lei Liang, Tian-Wei Fu, Mu-Gen Dai, Jian Cheng, Si-Yu Liu in BMC Cancer (2023)

  15. Article

    Open Access

    Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial

    Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the effic...

    Zhongjun **a, Yun Leng, Baijun Fang, Yang Liang, Wei Li, Chengcheng Fu in BMC Cancer (2023)

  16. Article

    Open Access

    Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

    Novel and effective immunotherapies are required for refractory or recurrent sarcomas. Transforming growth factor-beta (TGF-β) is a diverse regulatory and fibrogenic protein expressed in multiple sarcoma tumo...

    Lu **e, **n Liang, Jie Xu, **n Sun, Kuisheng Liu, Kunkun Sun, Yuan Li in BMC Cancer (2023)

  17. Article

    Open Access

    First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study

    This study aimed to compare the efficacy and safety of high-dose methotrexate (HD-MTX) versus teniposide (TEN) in patients with newly diagnosed immunocompetent primary central nervous system lymphomas (PCNSLs).

    Kaili Zhong, Yanyan Shi, Yuhuan Gao, Huilai Zhang, Mingzhi Zhang in BMC Cancer (2023)

  18. Article

    Open Access

    The association of serum IL-33/ST2 expression with hepatocellular carcinoma

    IL-33 is a multifunctional cytokine with dual functions. However, the clinicopathological and prognostic significance of IL-33 in cancer patients, especially in patients with hepatocellular carcinoma (HCC), re...

    **aolan Pan, **feng Liu, Meiqin Li, Yihua Liang, Zhimin Liu, Ming Lao in BMC Cancer (2023)

  19. Article

    Open Access

    Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients

    To compare the clinical value of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and pegylated rhG-CSF(PEG-rhG-CSF) in early-stage breast cancer (EBC) patients receiving adjuvant chemotherapy...

    Yantao Jiang, Ju Zhang, Jianxin Zhong, Hao Liao, Jiayang Zhang, Yaxin Liu in BMC Cancer (2023)

  20. Article

    Open Access

    Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study

    Diagnosis and treatment of diffuse malignant peritoneal mesothelioma (DMPM) are still challenging. The aim of the present study was to explore the correlation between CD74, CD10, Ki-67 and clinicopathological ...

    Yufei Liang, Chunying Li, Yingying Liu, Liang Tian, Dongliang Yang in BMC Cancer (2023)

previous disabled Page of 5